We are Sorry, This Page doesn't Exist
La Jolla announces results from interim analysis of Phase 2 study of LJPC-401
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Protagonist announces results from re-analysis fo Phase 2 Propel study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Genentech announces interim results from Phase III IMpower010 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Baudax Bio announces publication of results from Phase IIIb study of ANJESO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021 BARDA contract award provides up to $86.8 million for exebacase development Strong fi.....»»
Rezolute announces study results from Phase 1a of RZ402
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sorrento Therapeutics announces results of Phase 1b study of COVI-MSC treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Jazz Pharma announces results from Phase 3 study of XywavTM oral solution
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam announces full "positive" results from HELIOS-A Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eiger BioPharma announces results from Phase 2 PREVENT study of Avexitide
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Metracrine announces publication of results from Phase 1b study of MET409
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BiomX announces "positive" results from Phase 1a pharmacokinetic study of BX002
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Brickell announces Japan Phase 3 study results for sofpironium bromide gel
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioMarin announces topline results from ongoing global Phase 3 GENEr8-1 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer announces "positive" results from Phase 3 pneumococcal vaccine study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill Biopharma announces publication of results of Phase 3 study of Talicia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Recce Pharmaceuticals Announces First-Quarter 2020 Financial Results and Provides Operational Highlights
Highlights: Strong cash position with reserves of AUD $4.09M Formalized a Phase I Clinical trial agreement to conduct a first-in-human study of RECCE® 327 Completed successful in-vivo toxicity st.....»»
Vaccinex announces interim results from CLASSICAL-Lung Phase 1b/2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Scynexis announces results from second Phase 3 study of oral ibrexafungerp
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immunovant announces clinical results from ongoing Phase 2a study of IMVT-1401
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»